Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A JOINT FRAMEWORK FOR 4D SEGMENTATION AND ESTIMATION OF SMOOTH TEMPORAL APPEARANCE CHANGES.
Beneficial Effect of Tolerogenic Dendritic Cells Pulsed with MOG Autoantigen in Experimental Autoimmune Encephalomyelitis.
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder.
Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management.
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects.
Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation.
Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.
Immunogenicity and other problems associated with the use of biopharmaceuticals.
Use of botulinum toxin for genitourinary conditions: What is the evidence?
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation.
Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
JC Virus Replication at the First Symptoms of Multiple Sclerosis: A Case Report.
Antigen-Specific Binding of Multivalent Soluble Antigen Arrays Induces Receptor Clustering and Impedes B Cell Receptor Mediated Signaling.
Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study.
Sex-related differences in atrophy and lesion load in multiple sclerosis patients.
Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab.
Microarray gene expression profiling analysis combined with bioinformatics in multiple sclerosis.
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients.
The human JC polyomavirus (JCPyV): virological background and clinical implications.
Protective and Detrimental Roles for Regulatory T Cells in a Viral Model for Multiple Sclerosis.
Comparison of Sleep Problems in Individuals with Spinal Cord Injury and Multiple Sclerosis.
Inherited and acquired disorders of myelin: The underlying myelin pathology.
Pages
« first
‹ previous
…
430
431
432
433
434
435
436
437
438
…
next ›
last »